ACT NOW: EMA Urges Timely Submission for CTR Transition

With the CTR transition deadline approaching, Ergomed’s Regulatory Dashboard offers biotech and pharma companies an essential roadmap to meet the October 16, 2024, expedited transition deadline.

 
Only 30% of clinical trials have moved from the Clinical Trial Directive (CTD) to the CTR, leaving sponsors at risk of delays and backlog if they miss this critical window. This whitepaper, led by Ergomed’s seasoned regulatory experts, highlights key steps and best practices, from document harmonization to CTIS portal navigation, designed to help you meet regulatory requirements smoothly and avoid disruptions.
 
Stay ahead of the regulatory shift and streamline your transition with insights and strategic planning guidance from Ergomed.

"*" indicates required fields

Please enter your details to get access to the resource

By submitting this form, you consent to your personal data submitted in the form being processed in alignment with our Online Privacy and Cookies policy. Your personal data will be processed to facilitate your request and may be used for sending you additional marketing and business development-related information about Ergomed, its affiliates, and our services. You can withdraw your consent anytime by messaging marketing@ergomedgroup.com, and we will promptly remove your data from our records. For more information about how we will process your personal data and your rights, please see our Online Privacy and Cookies policy.
This field is for validation purposes and should be left unchanged.